This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-outlook: Archive
Bank of Hawaii (BOH) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Bank of Hawaii (BOH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
BOHNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Zurn Water (ZWS) Rating Upgrade to Strong Buy
by Zacks Equity Research
Zurn Water (ZWS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
ZWSPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Vontier (VNT) Upgraded to Buy: Here's Why
by Zacks Equity Research
Vontier (VNT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
VNTNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Alexander's (ALX) Lags Q2 FFO and Revenue Estimates
by Zacks Equity Research
Alexander's (ALX) delivered FFO and revenue surprises of -6.49% and -0.60%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ALXPositive Net Change DEANegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
ON Semiconductor Corp. (ON) Q2 Earnings Miss Estimates
by Zacks Equity Research
ON Semiconductor Corp. (ON) delivered earnings and revenue surprises of -1.85% and +1.30%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ONNegative Net Change ADINegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
LMNDPositive Net Change MSNegative Net Change
earnings-esp earnings-expectations earnings-outlook
These 2 Auto, Tires and Trucks Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
RIVNNegative Net Change MGANegative Net Change
earnings-esp earnings-expectations earnings-outlook
These 2 Business Services Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
GENNegative Net Change FISNegative Net Change
earnings-esp earnings-expectations earnings-outlook
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
PFEPositive Net Change OGNNegative Net Change
earnings-esp earnings-expectations earnings-outlook
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
AMGNNegative Net Change HALOPositive Net Change
earnings-esp earnings-expectations earnings-outlook
These 2 Industrial Products Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
PHNegative Net Change HUBBNegative Net Change
earnings-esp earnings-expectations earnings-outlook
Why Investors Need to Take Advantage of These 2 Auto, Tires and Trucks Stocks Now
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
CMIPositive Net Change PIIPositive Net Change
earnings-esp earnings-expectations earnings-outlook
How to Find Strong Consumer Staples Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
ELFNegative Net Change CLPositive Net Change
earnings-esp earnings-expectations earnings-outlook
Lindblad Expeditions (LIND) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Lindblad Expeditions (LIND) delivered earnings and revenue surprises of +37.93% and +5.27%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
LINDPositive Net Change VIKNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Tyson Foods (TSN) Q3 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Tyson (TSN) delivered earnings and revenue surprises of +26.39% and +1.88%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
TSNPositive Net Change BYNDNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Twist Bioscience (TWST) delivered earnings and revenue surprises of +12.96% and +0.60%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
TWSTNegative Net Change TCRXPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
BioCryst Pharmaceuticals (BCRX) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
BioCryst (BCRX) delivered earnings and revenue surprises of +400.00% and +9.74%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
BCRXNegative Net Change ZTSNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Krystal Biotech, Inc. (KRYS) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Krystal Biotech (KRYS) delivered earnings and revenue surprises of +19.44% and +6.12%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
KRYSNegative Net Change PHATNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Bruker (BRKR) Misses Q2 Earnings Estimates
by Zacks Equity Research
Bruker (BRKR) delivered earnings and revenue surprises of -3.03% and +0.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
BRKRNegative Net Change AVTNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
TG Therapeutics (TGTX) Misses Q2 Earnings Estimates
by Zacks Equity Research
TG Therapeutics (TGTX) delivered earnings and revenue surprises of -46.88% and +3.75%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
TGTXNegative Net Change EXASPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Wayfair (W) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Wayfair (W) delivered earnings and revenue surprises of +141.67% and +4.25%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
WNegative Net Change CPNGNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Axsome Therapeutics (AXSM) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Axsome (AXSM) delivered earnings and revenue surprises of +8.00% and +7.47%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AXSMNegative Net Change IFRXPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Hagerty, Inc. (HGTY) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Hagerty (HGTY) delivered earnings and revenue surprises of +18.18% and +4.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
HGTYPositive Net Change HRTGPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Freshpet (FRPT) Tops Q2 Earnings Estimates
by Zacks Equity Research
Freshpet (FRPT) delivered earnings and revenue surprises of +175.00% and -1.25%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
FRPTNegative Net Change USFDNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Idexx Laboratories (IDXX) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Idexx (IDXX) delivered earnings and revenue surprises of +9.67% and +4.01%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
IDXXNegative Net Change OFIXPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank